Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts.
Francisco Javier Ruperti-RepiladoDaniel ToblerMatthias GreutmannJudith BouchardyMagalie LadouceurLaura Dos-SubiraPastora GallegoHarald GabrielBerto BoumaMarkus Schwerzmannnull nullPublished in: Open heart (2021)
Pulmonary arterial hypertension, Fontan palliation and cyanotic heart disease were widely considered as risk factors for poor outcome in COVID-19. However, there was a marked disparity in risk estimation for other clinical scenarios. We are in urgent need of outcome studies in ACHD suffering from COVID-19.